PeterBlankestijn NetherlandsUniversity Medical Center Utrecht

PeterBlankestijn
Curriculum vitae of Prof Peter J. Blankestijn Peter J. Blankestijn did his medical school and training in internal medicine at the Erasmus University and Erasmus Medical Center in Rotterdam and worked as a nephrologist at the department of Nephrology and Hypertension of the University Medical Center Utrecht (UMCU), the Netherlands. Main research activities include studies in humans. Subjects are: 1] hypertension, with special interest for hypertension in chronic kidney disease patients, for the sympathetic nervous system and renal denervation. 2] treatment and prevention of complications of chronic kidney disease patients, 3] hemodialysis techniques, and 4] treatment and prevention of complications of hemodialysis treatment. He was and is principal investigator of several multicenter studies, including SMASH, MASTERPLAN, CONTRAST, SYMPATHY and CONVINCE. He received multiple grants from (inter)national organizations as well as of pharmaceutical, dialysis and medical devices industries. He acquired a large grant in the HORIZON 2020 program of the European Commission as chair of the CONVINCE consortium. He is (co)author of approximately 400 papers in peer reviewed scientific medical journals (Google Scholar H-index 81, > 22.000 citations).
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/87150a7c4e77aa9f9f13d04c982d7826.jpg
First Name
Peter
Last Name
Blankestijn
Institution
Country.
Netherlands

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
HIT2
DavidWheeler Chair United KingdomUniversity College London
Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong
  • What Have We Learned From CONVINCE?
    HIT2-1
    PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    HIT2-2
    VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    HIT2-3
    JonathanBarratt Oral Abstract Presenter United KingdomUniversity of Leicester, Leicester, UK
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    HIT2-4
    KateBramham Oral Abstract Presenter United KingdomKing's College London
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    HIT2-5
    Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India
    SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore
Brahmkamal Hall - Plenary Hall